CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) announced today that it has priced a public offering of 19,000,000 shares of its common stock at a price of $1.75 per share. Net proceeds after underwriting discounts and commissions and expenses will be approximately $30.9 million. ARIAD has granted the underwriters a thirty-day option to purchase up to an additional 2,850,000 shares to cover over-allotments, if any which will result in additional net proceeds of approximately $4.7 million, if exercised. The offering is expected to close on or about August 7, 2009, subject to satisfaction of customary closing conditions.
